Aller au contenu principal
Accès ouvert déclaré 2026 article

Māori and Pacific People’s perspectives on Group A Streptococcus vaccine development and delivery in Aotearoa, New Zealand

0Citations signalées, ce qui n’est pas une note de qualité
3Institutions déclarées
1Pays d’affiliation déclarés

Rattachement africain : nz. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Aotearoa New Zealand experiences a disproportionately high incidence of Group A Streptococcus (Strep A) disease, particularly acute rheumatic fever (ARF), with Pacific children 80 times and Indigenous Māori children 36 times more likely to develop ARF than children of other ethnicities. This qualitative study explored Māori and Pacific Peoples' perspectives on Strep A vaccine development. Guided by Kaupapa Māori and Pacific-centred research approaches, semi-structured interviews were conducted with 29 participants, including 20 whānau (family) members and nine healthcare stakeholders. Interviews were recorded, transcribed verbatim, and analysed using a general inductive thematic approach. Three interconnected themes emerged: Perceptions of ARF, vaccine development, and vaccine delivery. These themes were grounded in cultural values such as hauora (wellbeing), whanaungatanga (relationships), kotahitanga (collective action), and tino rangatiratanga (sovereignty and self-determination). Participants' perspectives were shaped by lived experiences of colonisation and the recent Covid-19 vaccine rollout. Māori and Pacific-led approaches rooted in cultural knowledge systems were consistently highlighted. Participants emphasised that the current healthcare system is not fit-for-purpose for Māori and Pacific health and wellbeing and must be realigned to better reflect varying worldviews. Vaccine delivery models must be holistic and flexible, incorporating a whānau ora (family-centred) approach. While recognising the importance of a Strep A vaccine, participants stressed that addressing social determinants of health, such as housing, poverty, and access to health care is essential to reducing disease burden. These findings demonstrate that culturally responsive approaches are essential for successful vaccination programmes. In Aotearoa New Zealand, this requires embedding Māori and Pacific leadership, perspectives and participation from design to delivery, together with strengthened Māori and Pacific health workforces.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Māori and Pacific People’s perspectives on Group A Streptococcus vaccine development and delivery in Aotearoa, New Zealand
Date Crossref
04/02/2026
Éditeur
Public Library of Science (PLoS)
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Streptococcal Infections and TreatmentsOral microbiology and periodontitis researchNeonatal and Maternal Infections

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.